We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Novel High-Throughput Screen Focuses on Appetite Regulating Enzyme

By LabMedica International staff writers
Posted on 25 Nov 2010
A fluorescence-based assay method has been used as a high-throughput screen for drugs to inhibit the enzyme ghrelin O-acyltransferase (GOAT), which is critically linked to molecular pathways regulating appetite.

Ghrelin is a 28 amino acid, appetite-stimulating peptide hormone secreted by the food-deprived stomach. Serine-3 of ghrelin is acylated with an eight-carbon fatty acid, octanoate, which is required for its endocrine actions.

GOAT is a membrane-bound enzyme that attaches octanoate to serine-3 of ghrelin. Analysis of the mouse genome has revealed that GOAT belongs to a family of 16 hydrophobic membrane-bound acyltransferases. GOAT is the only member of this family that octanoylates ghrelin when coexpressed in cultured endocrine cell lines with prepro-ghrelin. GOAT activity requires catalytic asparagine and histidine residues that are conserved in this family. Consistent with its function, GOAT mRNA is largely restricted to stomach and intestine, the major ghrelin-secreting tissues.

Investigators at the Scripps Research Institute (La Jolla, CA, USA) applied a novel fluorescence-based assay to the problem of assessing GOAT activity. The assay, which they called cat-ELCCA (catalytic assay using enzyme-linked click chemistry assay), associates "click chemistry” with an ELISA-style approach. Click chemistry is a proprietary development of the Scripps Research Institute.

"There has not been a simple screen until now,” said senior author Dr. Kim D. Janda, professor of chemistry and immunology at the Scripps Research Institute. Dr. Janda and his research associate Dr. Amanda Garner reported in the September 15, 2010, online edition of the journal Angewandte Chemie that "This new assay technology is both highly sensitive and reproducible, making it an excellent assay for high-throughput screening.”

Related Links:
Scripps Research Institute


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test

Latest BioResearch News

Circulating Tumor DNA Helps Identify Targets for Personalized Immunotherapy
25 Nov 2010  |   BioResearch

Researchers Classify 108 Lysosomal Disorders in Updated Diagnostic Framework
25 Nov 2010  |   BioResearch

New Autoantibody Target Identified in Neuromyelitis Optica Spectrum Disorder
25 Nov 2010  |   BioResearch